387 related articles for article (PubMed ID: 27641812)
1. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
[TBL] [Abstract][Full Text] [Related]
2. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
[TBL] [Abstract][Full Text] [Related]
3. Slow R-warfarin 7-hydroxylation mediated by P450 2C19 genetic variants in cynomolgus monkeys in vivo.
Utoh M; Yoshikawa T; Hayashi Y; Shimizu M; Iwasaki K; Uno Y; Yamazaki H
Biochem Pharmacol; 2015 May; 95(2):110-4. PubMed ID: 25801008
[TBL] [Abstract][Full Text] [Related]
4. Individual Differences in Metabolic Clearance of S-Warfarin Efficiently Mediated by Polymorphic Marmoset Cytochrome P450 2C19 in Livers.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jul; 44(7):911-5. PubMed ID: 27098744
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants.
Nakanishi K; Uehara S; Kusama T; Inoue T; Shimura K; Kamiya Y; Murayama N; Shimizu M; Uno Y; Sasaki E; Yamazaki H
Biochem Pharmacol; 2018 Jun; 152():272-278. PubMed ID: 29626440
[TBL] [Abstract][Full Text] [Related]
6. Regio- and Stereo-Selective Oxidation of a Cardiovascular Drug, Metoprolol, Mediated by Cytochrome P450 2D and 3A Enzymes in Marmoset Livers.
Uehara S; Ishii S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 Aug; 45(8):896-899. PubMed ID: 28495902
[TBL] [Abstract][Full Text] [Related]
7. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
8. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
Hosoi Y; Uno Y; Murayama N; Fujino H; Shukuya M; Iwasaki K; Shimizu M; Utoh M; Yamazaki H
Biochem Pharmacol; 2012 Dec; 84(12):1691-5. PubMed ID: 23041648
[TBL] [Abstract][Full Text] [Related]
9. Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone.
Uehara S; Uno Y; Nakanishi K; Ishii S; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 May; 45(5):457-467. PubMed ID: 28196829
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2018 Jul; 153():184-195. PubMed ID: 29277691
[TBL] [Abstract][Full Text] [Related]
11. Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models.
Kusama T; Toda A; Shimizu M; Uehara S; Inoue T; Uno Y; Utoh M; Sasaki E; Yamazaki H
Xenobiotica; 2018 Oct; 48(10):1072-1077. PubMed ID: 29034770
[TBL] [Abstract][Full Text] [Related]
12. CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques.
Uno Y; Matsushita A; Shukuya M; Matsumoto Y; Murayama N; Yamazaki H
Biochem Pharmacol; 2014 Sep; 91(2):242-8. PubMed ID: 25036290
[TBL] [Abstract][Full Text] [Related]
13. R-warfarin clearances from plasma associated with polymorphic cytochrome P450 2C19 and simulated by individual physiologically based pharmacokinetic models for 11 cynomolgus monkeys.
Utoh M; Kusama T; Miura T; Mitsui M; Kawano M; Hirano T; Shimizu M; Uno Y; Yamazaki H
Xenobiotica; 2018 Feb; 48(2):206-210. PubMed ID: 28136132
[TBL] [Abstract][Full Text] [Related]
14. Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents.
Uehara S; Uno Y; Suzuki T; Inoue T; Utoh M; Sasaki E; Yamazaki H
Drug Metab Lett; 2017; 10(4):244-253. PubMed ID: 27842484
[TBL] [Abstract][Full Text] [Related]
15. Progesterone hydroxylation by cytochromes P450 2C and 3A enzymes in marmoset liver microsomes.
Nakanishi K; Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2018 Aug; 48(8):757-763. PubMed ID: 28762864
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys.
Shimizudani T; Nagaoka K; Hanioka N; Yamano S; Narimatsu S
Chem Biol Interact; 2010 Jan; 183(1):67-78. PubMed ID: 19853591
[TBL] [Abstract][Full Text] [Related]
17. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
[TBL] [Abstract][Full Text] [Related]
18. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
[TBL] [Abstract][Full Text] [Related]
19. A New Marmoset P450 4F12 Enzyme Expressed in Small Intestines and Livers Efficiently Metabolizes Antihistaminic Drug Ebastine.
Uehara S; Uno Y; Yuki Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jun; 44(6):833-41. PubMed ID: 27044800
[TBL] [Abstract][Full Text] [Related]
20. Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6.
Uehara S; Murayama N; Yamazaki H; Suemizu H
Xenobiotica; 2019 Nov; 49(11):1323-1331. PubMed ID: 30596462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]